Vasopressin and oxytocin in CSF and plasma of patients with aneurysmal subarachnoid haemorrhage

Neuropeptides

Volumn 48, Issue 2, 2014, Pages 91-96

  Martin, Jan ^a   Kagerbauer, Simone M ^a   Schuster, Tibor ^b   Blobner, Manfred ^a   Kochs, Eberhard F ^a   Landgraf, Rainer ^c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Aneurysmal; CSF; Haemorrhage; Oxytocin; Plasma; Subarachnoid; Vasopressin

Indexed keywords

ARGIPRESSIN; NEUROPEPTIDE; OXYTOCIN; VASOPRESSIN; BIOLOGICAL MARKER; VASOPRESSIN DERIVATIVE;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FUNCTIONAL STATUS; GLASGOW OUTCOME SCALE; HUMAN; MALE; MIDDLE AGED; PLASMA; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SUBARACHNOID HEMORRHAGE; YOUNG ADULT; BLOOD; HYPOTHALAMUS; METABOLISM; PATHOPHYSIOLOGY; PROGNOSIS; REGRESSION ANALYSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; GLASGOW OUTCOME SCALE; HUMANS; HYPOTHALAMUS; MALE; MIDDLE AGED; OXYTOCIN; PROGNOSIS; REGRESSION ANALYSIS; SUBARACHNOID HEMORRHAGE; VASOPRESSINS; YOUNG ADULT;

EID: 84896542133     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2013.12.004     Document Type: Article

References (54)

1. Ang B.T., Tan W.L., Lim J., Ng I. Cerebrospinal fluid orexin in aneurysmal subarachnoid haemorrhage - a pilot study. J. Clin. Neurosci. Official J. Neurosurg. Soc. Australasia 2005, 12:758-762.
2. Barry C.M., Helps S.C., den Heuvel C., Vink R. Characterizing the role of the neuropeptide substance P in experimental subarachnoid hemorrhage. Brain Res. 2011, 1389:143-151.
3. Berry E., Jones R.A., West C.G., Brown J.D. Outcome of subarachnoid haemorrhage. An analysis of surgical variables, cognitive and emotional sequelae related to SPECT scanning. Br. J. Neurosurg. 1997, 11:378-387.
4. Bielsky I.F., Young L.J. Oxytocin, vasopressin, and social recognition in mammals. Peptides 2004, 25:1565-1574.
5. Bosch O.J., Neumann I.D. Brain vasopressin is an important regulator of maternal behavior independent of dams' trait anxiety. Proc. Natl. Acad. Sci. USA 2008, 105:17139-17144.
6. Caeiro L., Santos C.O., Ferro J.M., Figueira M.L. Neuropsychiatric disturbances in acute subarachnoid haemorrhage. Eur. J. Neurol. Official J. Eur. Fed. Neurol. Soc. 2011, 18:857-864.
7. Cahill J., Calvert J.W., Zhang J.H. Mechanisms of early brain injury after subarachnoid hemorrhage. J. Cerebral Blood Flow Metab. official J. Int. Soc. Cerebral Blood Flow Metab. 2006, 26:1341-1353.
8. Crompton M.R. Hypothalamic lesions following the rupture of cerebral berry aneurysms. Brain J. Neurol. 1963, 86:301-314.
9. Delgado T.J., Arbab M.A., Warberg J., Svendgaard N.A. The role of vasopressin in acute cerebral vasospasm. Effect on spasm of a vasopressin antagonist or vasopressin antiserum. J. Neurosurg. 1988, 68:266-273.
10. Dohi K., Ripley B., Fujiki N., Ohtaki H., Shioda S., Aruga T., Nishino S. CSF hypocretin-1/orexin-A concentrations in patients with subarachnoid hemorrhage (SAH). Peptides 2005, 26:2339-2343.
11. Donaldson Z.R., Young L.J. Oxytocin, vasopressin, and the neurogenetics of sociality. Science 2008, 322:900-904.
12. Doshi R., Neil-Dwyer G. A clinicopathological study of patients following a subarachnoid hemorrhage. J. Neurosurg. 1980, 52:295-301.
13. Fertl E., Killer M., Eder H., Linzmayer L., Richling B., Auff E. Long-term functional effects of aneurysmal subarachnoid haemorrhage with special emphasis on the patient's view. Acta Neurochir. 1999, 141:571-577.
14. Fisher C.M. Clinical syndromes in cerebral thrombosis, hypertensive hemorrhage, and ruptured saccular aneurysm. Clin. Neurosurg. 1975, 22:117-147.
15. Fisher C.M., Kistler J.P., Davis J.M. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980, 6:1-9.
16. Gabor C.S., Phan A., Clipperton-Allen A.E., Kavaliers M., Choleris E. Interplay of oxytocin, vasopressin, and sex hormones in the regulation of social recognition. Behav. Neurosci. 2012, 126:97-109.
17. Giraldo E.A., Mandrekar J.N., Rubin M.N., Dupont S.A., Zhang Y., Lanzino G., Wijdicks E.F., Rabinstein A.A. Timing of clinical grade assessment and poor outcome in patients with aneurysmal subarachnoid hemorrhage. J. Neurosurg. 2012, 117:15-19.
18. Gossen A., Hahn A., Westphal L., Prinz S., Schultz R.T., Grunder G., Spreckelmeyer K.N. Oxytocin plasma concentrations after single intranasal oxytocin administration - a study in healthy men. Neuropeptides 2012, 46:211-215.
19. Hackett M.L., Anderson C.S. Health outcomes 1year after subarachnoid hemorrhage: an international population-based study. The Australian Cooperative Research on Subarachnoid Hemorrhage Study Group. Neurology 2000, 55:658-662.
20. Hunt W.E., Hess R.M. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J. Neurosurg. 1968, 28:14-20.
21. Hutter B.O., Gilsbach J.M. Which neuropsychological deficits are hidden behind a good outcome (Glasgow=I) after aneurysmal subarachnoid hemorrhage. Neurosurgery 1993, 33:999-1005. (discussion 1005-1006).
22. Jarcho M.R., Mendoza S.P., Mason W.A., Yang X., Bales K.L. Intranasal vasopressin affects pair bonding and peripheral gene expression in male Callicebus cupreus. Genes Brain Behav. 2011, 10:375-383.
23. Jennett B., Bond M. Assessment of outcome after severe brain damage. Lancet 1975, 1:480-484.
24. Johnston S.C., Selvin S., Gress D.R. The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology 1998, 50:1413-1418.
25. Kagerbauer S.M., Martin J., Schuster T., Blobner M., Kochs E.F., Landgraf R. Plasma oxytocin and vasopressin do not predict neuropeptide concentrations in the human cerebrospinal fluid. J. Neuroendocrinol. 2013, 25:668-673.
26. Kassell N.F., Torner J.C., Haley E.C., Jane J.A., Adams H.P., Kongable G.L. The international cooperative study on the timing of aneurysm surgery. Part 1: Overall management results. J. Neurosurg. 1990, 73:18-36.
27. Kleindienst A., Hildebrandt G., Kroemer S.A., Franke G., Gaab M.R., Landgraf R. Hypothalamic neuropeptide release after experimental subarachnoid hemorrhage: in vivo microdialysis study. Acta Neurol. Scand. 2004, 109:361-368.
28. Kuboyama T., Hashimoto H., Ueguchi T., Yamaki T., Hirakawa K., Noto T., Nakajima T. Diurnal changes in vasopressin and oxytocin levels in cerebrospinal fluid of post-operative patients with intracranial aneurysms. Endocrinologia Japonica 1988, 35:249-254.
29. Kusaka G., Ishikawa M., Nanda A., Granger D.N., Zhang J.H. Signaling pathways for early brain injury after subarachnoid hemorrhage. J. Cerebral Blood Flow Metab. Official J. Int. Soc. Cerebral Blood Flow Metab. 2004, 24:916-925.
30. Landgraf R., Neumann I.D. Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front. Neuroendocrinol. 2004, 25:150-176.
31. Leng G., Ludwig M. Neurotransmitters and peptides: whispered secrets and public announcements. J. Physiol. 2008, 586:5625-5632.
32. Linn F.H., Rinkel G.J., Algra A., van Gijn J. Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke J. Cerebral Circ. 1996, 27:625-629.
33. Lukas M., Toth I., Reber S.O., Slattery D.A., Veenema A.H., Neumann I.D. The neuropeptide oxytocin facilitates pro-social behavior and prevents social avoidance in rats and mice. Neuropsychopharmacol. Official Publ. Am. Coll. Neuropsychopharmacol. 2011, 36:2159-2168.
34. Macdonald R.L. Outcome after aneurysmal subarachnoid hemorrhage. J. Neurosurg. 2012, 117:12-14. (discussion 14).
35. Macdonald R.L., Pluta R.M., Zhang J.H. Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution. Nat. Clin. Pract. Neurol. 2007, 3:256-263.
36. Mather H.M., Ang V., Jenkins J.S. Vasopressin in plasma and CSF of patients with subarachnoid haemorrhage. J. Neurol. Neurosurg. Psychiatry 1981, 44:216-219.
37. Mayer S.A., Kreiter K.T., Copeland D., Bernardini G.L., Bates J.E., Peery S., Claassen J., Du Y.E., Connolly E.S. Global and domain-specific cognitive impairment and outcome after subarachnoid hemorrhage. Neurology 2002, 59:1750-1758.
38. Mcburney D.M., White T.L. Research Methods 2004, Wadsworth, Belmont, CA.
39. McKenna P., Willison J.R., Phil B., Lowe D., Neil-Dwyer G. Cognitive outcome and quality of life 1year after subarachnoid haemorrhage. Neurosurgery 1989, 24:361-367.
40. Neil-Dwyer G., Lang D.A., Doshi B., Gerber C.J., Smith P.W. Delayed cerebral ischaemia: the pathological substrate. Acta Neurochir. 1994, 131:137-145.
41. Neumann I.D., Landgraf R. Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors. Trends Neurosci. 2012, 35:649-659.
42. Nishihashi T., Trandafir C.C., Wang A., Ji X., Kurahashi K. Enhanced reactivity to vasopressin in rat basilar arteries during vasospasm after subarachnoid hemorrhage. Eur. J. Pharmacol. 2005, 513:93-100.
43. Ogden J.A., Mee E.W., Henning M. A prospective study of impairment of cognition and memory and recovery after subarachnoid hemorrhage. Neurosurgery 1993, 33:572-586. (discussion 586-587).
44. Powell J., Kitchen N., Heslin J., Greenwood R. Psychosocial outcomes at 3 and 9months after good neurological recovery from aneurysmal subarachnoid haemorrhage: predictors and prognosis. J. Neurol. Neurosurg. Psychiatry 2002, 72:772-781.
45. Rosengart A.J., Schultheiss K.E., Tolentino J., Macdonald R.L. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke J. Cerebral Circ. 2007, 38:2315-2321.
46. Sala M., Braida D., Lentini D., Busnelli M., Bulgheroni E., Capurro V., Finardi A., Donzelli A., Pattini L., Rubino T., Parolaro D., Nishimori K., Parenti M., Chini B. Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. Biol. Psychiatry 2011, 69:875-882.
47. Schebesch K.M., Brawanski A., Kagerbauer S.M., Martin J., Bele S., Herbst A., Feigl G., Stoerr E.M., Lohmeier A., Proescholdt M. The possible role of neuropeptide Y after spontaneous subarachnoid hemorrhage. Acta Neurochirurgica 2011, 153:1663-1668. (discussion 1668).
48. Sehba F.A., Bederson J.B. Mechanisms of acute brain injury after subarachnoid hemorrhage. Neurol. Res. 2006, 28:381-398.
49. Teasdale G.M., Drake C.G., Hunt W., Kassell N., Sano K., Pertuiset B., de Villiers J.C. A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J. Neurol. Neurosurg. Psychiatry 1988, 51:1457.
50. Trandafir C.C., Nishihashi T., Wang A., Murakami S., Ji X., Kurahashi K. Participation of vasopressin in the development of cerebral vasospasm in a rat model of subarachnoid haemorrhage. Clin. Exp. Pharmacol. Physiol. 2004, 31:261-266.
51. Uski T.K., Lilja A., Saveland H., Ekman R., Sonesson B., Brandt L. Cognitive functioning and cerebrospinal fluid concentrations of neuropeptides for patients with good neurological outcomes after aneurysmal subarachnoid hemorrhage. Neurosurgery 2000, 47:812-818.
52. van Gijn J., Kerr R.S., Rinkel G.J. Subarachnoid haemorrhage. Lancet 2007, 369:306-318.
53. Voldby B., Enevoldsen E.M. Intracranial pressure changes following aneurysm rupture. Part 1: Clinical and angiographic correlations. J. Neurosurg. 1982, 56:186-196.
54. Zhu X.D., Chen J.S., Zhou F., Liu Q.C., Chen G., Zhang J.M. Detection of copeptin in peripheral blood of patients with aneurysmal subarachnoid hemorrhage. Crit. Care 2011, 15:R288.